APOL1 risk alleles modulate T cell receptor signaling to promote allograft rejection
Journal of Clinical Investigation · 03.08.2026 · 136 (15)
DOI: 10.1172/jci193173 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 09.06.2026. Verfasst von John Pell und 33 weiteren Autor:innen. Beteiligte Einrichtung: Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Apolipoprotein L1, Receptors, Antigen, T-Cell, CD8-Positive T-Lymphocytes, Graft Rejection. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIAID NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
The exonic variants G1 and G2 in apolipoprotein-L1 (APOL1) are linked to an increased risk of kidney disease as well as kidney transplant rejection. Outside of the association of these prevalent variants with African ancestry, the underpinning causal mechanisms for rejection are unknown. We investigated T cell function using transgenic mice with physiologic expression of WT (G0), G1 APOL1 (G1), or G2 APOL1 (G2). Mice with the G1 or G2 variant showed greater CD8 + T cell activation with expansion of a central memory T cell (Tcm) subset. Stimulated G1 CD8 + T cells showed enhanced proliferation and cytokine production, which was reversed with APOL1 inhibition. In MHC-mismatched cardiac transplants, G1 mice demonstrated greater CD8 + T cell infiltration and worse survival. The bulk transcriptome of G1 CD8 + T cells and the single-cell transcriptome of graft-infiltrating Tcms showed enrichment of canonical T cell receptor (TCR) pathways including Ca 2+ signaling. G1 CD8 + T cells demonstrated baseline ER Ca 2+ depletion followed by sustained increases in cytosolic Ca 2+ upon TCR stimulation. G1 CD8 + T cells were more sensitive to Ca 2+ chelation, or store-operated Ca 2+ entry inhibition, and were relatively resistant to calcineurin antagonism compared with G0 CD8 + T cells. Analogously, in a kidney transplant cohort, transplant recipients carrying an APOL1 risk variant (G1 or G2) who had elevated peripheral Tcms before transplantation developed rejection despite having significantly higher tacrolimus levels than recipients with the G0/G0 APOL1 genotype. In summary, we have unraveled an excitatory mechanism for APOL1 variants in T cells that causally links them to kidney rejection. We show that APOL1 variants promote CD8+T-cell activation via Ca2+ signaling, causally explaining their link to kidney rejection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut, USA.
- Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Section of Digestive Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
- Transplant Research Center, Division of Renal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Division of Nephrology, Washington University, St. Louis, Missouri, USA.
- Department of Surgery, The University of Chicago, Chicago, Illinois, USA.
Förderung
- NIDDK NIH HHS
- NIAID NIH HHS
- National Institutes of Health
- U.S. Department of Defense
Zitieren
APA
Pell, J., Tanvir, E. M., Sun, Z., Chernova, I., Reghuvaran, A., Nagata, S., Guerra, M. T., Choi, J., Al Chaar, S., Mizuno, H., Dong, K., Tian, X., Ishibe, R., Franchin, B., Cravedi, P., Kumar, A., Barsotti, G., Shi, H., De Kumar, B., …, & Menon, M. C. (2026). APOL1 risk alleles modulate T cell receptor signaling to promote allograft rejection. Journal of Clinical Investigation, 136(15). https://doi.org/10.1172/jci193173
Vancouver
Pell J, Tanvir EM, Sun Z, Chernova I, Reghuvaran A, Nagata S, et al. APOL1 risk alleles modulate T cell receptor signaling to promote allograft rejection. Journal of Clinical Investigation. 2026;136(15). doi:10.1172/jci193173
BibTeX
@article{Pell2026,
author = {Pell, John and Tanvir, E M and Sun, Zeguo and Chernova, Irene and Reghuvaran, Anand and Nagata, Soichiro and Guerra, Mateus T and Choi, John and Al Chaar, Soltan and Mizuno, Hiroki and Dong, Ke and Tian, Xin and Ishibe, Reika and Franchin, Barbara and Cravedi, Paolo and Kumar, Ashwani and Barsotti, Gabriel and Shi, Hongmei and De Kumar, Bony and Smithson, Shinobu and Song, Wenzhi and He, John Cijiang and Chong, Anita S and Pober, Jordan S and Somlo, Stefan and Gibson, Ian W and Popik, Waldemar and Zhang, Zhongyang and Craft, Joseph and Azzi, Jamil and Murakami, Naoka and Ishibe, Shuta and Heeger, Peter S and Menon, Madhav C},
title = {APOL1 risk alleles modulate T cell receptor signaling to promote allograft rejection},
journal = {Journal of Clinical Investigation},
year = {2026},
volume = {136},
number = {15},
doi = {10.1172/jci193173}
}
EUVIMED